Cantargia (CAN10 IL1RAP Immunology Program) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Cantargia (CAN10 IL1RAP Immunology Program) General Information
Description
Early-clinical stage immunology program based in Tokyo, Japan. The CAN10 antibody binds strongly to its target, IL1RAP, and has a unique capability to simultaneously inhibit the signaling of cytokines from the IL-1 superfamily, including IL-1, IL-33, and IL-36.
Contact Information
Corporate Office
- Lund
- Sweden
Corporate Office
- Lund
- Sweden
Cantargia (CAN10 IL1RAP Immunology Program) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cantargia (CAN10 IL1RAP Immunology Program) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cantargia (CAN10 IL1RAP Immunology Program) FAQs
-
Where is Cantargia (CAN10 IL1RAP Immunology Program) headquartered?
Cantargia (CAN10 IL1RAP Immunology Program) is headquartered in Lund, Sweden.
-
What industry is Cantargia (CAN10 IL1RAP Immunology Program) in?
Cantargia (CAN10 IL1RAP Immunology Program)’s primary industry is Buildings and Property.
-
Is Cantargia (CAN10 IL1RAP Immunology Program) a private or public company?
Cantargia (CAN10 IL1RAP Immunology Program) is a Private company.
-
What is the current valuation of Cantargia (CAN10 IL1RAP Immunology Program)?
The current valuation of Cantargia (CAN10 IL1RAP Immunology Program) is .
-
What is Cantargia (CAN10 IL1RAP Immunology Program)’s current revenue?
The current revenue for Cantargia (CAN10 IL1RAP Immunology Program) is .
-
Who are Cantargia (CAN10 IL1RAP Immunology Program)’s investors?
Cantargia has invested in Cantargia (CAN10 IL1RAP Immunology Program).
-
When was Cantargia (CAN10 IL1RAP Immunology Program) acquired?
Cantargia (CAN10 IL1RAP Immunology Program) was acquired on 11-Sep-2025.
-
Who acquired Cantargia (CAN10 IL1RAP Immunology Program)?
Cantargia (CAN10 IL1RAP Immunology Program) was acquired by Otsuka Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process